50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Finjan’s mission is to invest in innovation and encourage the development of core intellectual property.”In use 2014 – now·1 sighting·SEC Form S-1/A, filed 2014-04-0790% match
“Our mission is to commercialize innovative drug candidates with novel mechanisms of action as well as intellectual property generated from our research activities for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-07-1666% match
“Our mission is to serve as a platform for the development and communication of new inventions.”In use 2012 – now·1 sighting·SEC Form S-1/A, filed 2012-09-0765% match
“Our mission is to create a better solution to the conventional IPO for these high growth, disruptive technology and technology-enabled companies, which addresses their needs for capital and liquidity, while overcoming the key points of friction in the traditional IPO path in particular for businesses in Japan.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1964% match
“Our mission is to empower the developers of a new Internet in creating Ethical Technologies through our Intellectual Property, providing advanced digital tools that enable developers and creators to build fair-forward solutions to build a new Ethical Internet Ecosystem (WEB.Ɛ).”In use 2022 – now·1 sighting·SEC Form S-1/A, filed 2022-06-0764% match
“Our mission is to be leaders in Israel’s biopharmaceutical industry, to identify promising drug compounds and creatively drive the development process towards commercialization.”In use 2020 – now·1 sighting·SEC Form 20-F, filed 2020-03-1264% match
“Our mission is to promote efficiency in social and economic development through technological innovation.”In use 2023 – now·1 sighting·SEC Form 424B4, filed 2023-03-1764% match
“To discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.”In use 2010 – now·1 sighting·SEC Form S-1/A, filed 2010-03-2564% match
“Our mission is to create a better solution to the conventional IPO for these high growth, disruptive technology and technology -enabled companies, which addresses their needs for capital and liquidity, while overcoming the key points of friction in the traditional IPO path.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-02-0264% match
“Our mission is to create a better solution to the conventional IPO for these high growth, disruptive technology and technology-enabled companies, which addresses their needs for capital and liquidity, while overcoming the key points of friction in the traditional IPO path.”In use 2021 – now·1 sighting·SEC Form S-1, filed 2021-03-0464% match
“Our mission is to advance to market novel regenerative medicine and cellular therapy products that substantially benefit humankind.”In use 2016 – now·1 sighting·SEC Form S-1/A, filed 2016-02-0263% match
RPRelx PlcCompany · Professional services · X0 Real “Our purpose is to benefit society by developing products that help researchers advance scientific knowledge; doctors and nurses improve the lives of patients; lawyers promote the rule of law and achieve justice andfair results for their clients; businesses and governments prevent fraud; consumers access financial services and get fair prices on insurance; and customers learn about markets and complete transactions.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-02-1963% match
“Our mission is to identify, acquire, and commercialize innovative proprietary ingredients and technologies to drive growth and deliver value.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0463% match
“Our mission is to invest in a company that can support this transition to a more inclusive and sustainable economy, and by doing so, achieve an attractive total return for investors.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2563% match
“Company’s mission is to partner with inventors, or other entities, who own undervalued intellectual property.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-03-3063% match
“Our mission is to create value from a diverse and distinctive portfolio of assets: an approved product, a pipeline with assets at all stages of development, and a productive research platform designed for long-term growth.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-03-0163% match
“Our mission is to enable the rapid development of innovative therapeutics by pushing the frontiers of drug discovery technologies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0463% match
“The Company's mission is to enable superior returns on our clients' technology investments through best-in-class vertical industry solutions, domain expertise, strategic partnerships with key technology leaders and global scale.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-06-1563% match
“Our mission is to improve the quality of people’s lives through the timely introduction of meaningful innovations.”In use 2008 – now·1 sighting·SEC Form 20-F, filed 2008-02-1962% match
“Our mission is to enhance the quality of life for families worldwide by leveraging two primary driving forces: technological intelligence and capital investments.”In use 2025 – now·1 sighting·SEC Form 20-F, filed 2025-10-2962% match
“Our mission is to apply technological innovation to become a globally prominent blockchain company.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-04-0262% match
“Our mission is to identify, acquire, and accelerate the development and commercialization of medicines that we believe have the potential to offer clinically meaningful, differentiated benefits to patients.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2862% match
“Our mission is to drive innovation and become a market leader in our industry by leveraging our design and intelligent technology to advance green mobility.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-2862% match
“Our mission is to become one of the key participants and contributors in the global technology hardware supply chain and fintech blockchain ecosystem.”In use 2025 – now·1 sighting·SEC Form 424B4, filed 2025-03-0462% match
“Our mission is to pioneer the application of blockchain and overlapping technologies to protect IP and the security of data and financial transactions.”In use 2018 – now·1 sighting·SEC Form S-1, filed 2018-04-2462% match
“The Company’s mission is to improve lives through product innovation, research and development and outstanding patient and consumer experience.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1362% match
“Our mission is to innovate product development that results in a better and healthier world, through our software and hardware infrastructure, and an in-depth knowledge of additive manufacturing.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-2362% match
“Our mission is to create differentiated, innovative products by applying our platform technologies to established or novel medicines.”In use 2008 – now·1 sighting·SEC Form 10-K, filed 2008-02-2962% match
“Our mission is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve the lives of our patients.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-0762% match
“Our mission is to innovate, design, and deliver semiconductor-based connectivity solutions that are purpose-built to unleash the full potential of cloud and AI infrastructure.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2062% match
“Our mission is to invest in innovative technologies integrated with business development in the healthcare ecosystem.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-04-1061% match
“Our mission is to enable enterprises to grow and innovate, securely and efficiently.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-02-2461% match
“Our mission is to identify and seize high-potential opportunities, delivering sustainable growth and maximizing returns on capital.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3061% match
“Our mission is to enrich clinical practice and the patient/consumer experience by developing and commercializing topically applied products which offer the benefits of our advanced bioactive small molecule peptide technology.”In use 2012 – now·1 sighting·SEC Form 10-K, filed 2012-03-2761% match
“Our mission is to use our technology to create a new generation of RNAi therapeutics which can improve outcomes for patients.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-09-0861% match
“Our mission is to develop products and services based on leading genomics technologies that improve outcomes and enable improved effectiveness, productivity and safety in the research efforts of drug discovery and development companies worldwide.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-03-1961% match
“Our mission is to identify and invest in business opportunities, apply our skills and resources to nurture and enhance the performance of those businesses across key business metrics, and to deliver accelerating shareholder value.”In use 2010 – now·1 sighting·SEC Form S-1/A, filed 2010-02-2661% match
“The Company's mission is to be a trusted knowledge partner for stakeholders, leading to growth in its businesses and continued creation of shareholder value.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-02-2661% match
“Our mission is to develop therapeutic products with the potential to address high unmet medical needs by identifying promising clinical-stage candidates and advancing their development to create products that will improve patients’ lives.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-08-2161% match
“Our mission is to invest in a technology company that capitalizes on these trends in digital transformation.”In use 2025 – now·1 sighting·SEC Form S-1, filed 2025-03-0361% match
“Our mission is to build a community and company capable of sustainably discovering, developing and delivering to patients innovative, important new medicines that will make a material difference in their health, well-being and lives.”In use 2009 – now·1 sighting·SEC Form 10-K, filed 2009-03-1361% match
“Our mission is to pursue the development of innovative product candidates designed to benefit the greatest number of patients.”In use 2021 – now·1 sighting·SEC Form 20-F, filed 2021-03-2561% match
“Our mission is to optimize business operations with our creative ideas and the use of blockchain technology.”In use 2026 – now·1 sighting·SEC Form 20-F/A, filed 2026-09-1861% match
“Our mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-05-2761% match
“Our mission is to provide drug and product developers with superior scientific research, high-quality research models and innovative analytical instrumentation in order to bring revolutionary new drugs and products to market quickly and safely.”In use 2021 – now·1 sighting·SEC Form S-1, filed 2021-12-2361% match
“Our mission is to build a world-class biopharmaceutical and biotechnology company, with a leading position in key therapeutic areas.”In use 2020 – now·1 sighting·SEC Form 20-F, filed 2020-03-1261% match
“Our mission is to “Lead Indonesian Digital Innovation and Globalization”.”In use 2018 – now·1 sighting·SEC Form 20-F, filed 2018-04-0961% match
“Our mission is to make promising innovation a reality faster and more efficiently.”In use 2024 – now·1 sighting·SEC Form S-1/A, filed 2024-06-0561% match
“Our mission is to improve the quality of life of people suffering from cancer and to increase shareholder value by commercializing our platform technologies through in-house development, joint ventures, strategic alliances and licensing arrangements.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-07-2961% match
“Our mission is to create disease-modifying neurogenetic medicines by identifying validated targets, advancing multiple therapeutic modalities, and delivering them to the right areas within the central nervous system.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1161% match
Showing 1–50 of 50